Aptamers Market: Adoption of Aptamers as Potential Substitutes to Antibodies to Entice Growth
Higher prevalence of chronic diseases has augmented adoption of advanced diagnostic means. Owing to their unique properties, aptameters can be generated faster than antibodies, hence favoring their adoption in disease therapeutics. Additionally, massive investments towards R&D developments across pharmaceutical and biotechnological verticals pertaining drug development are also accounted to substantiate favorable growth in global aptamers market on the back of large scale adoption in specific research initiatives.
View full press release